Research library · Genomics
A genetic risk headline needs a starting number
Draft • Research checked 4 October 2026 • AI-assisted DomDNA editorial content. No independent clinical review or publication is claimed. General education, not individual medical advice.
You open a headline about a genetic finding and see “50% higher risk”. Before deciding how worried to feel, you need the chance in the comparison group and the period the researchers studied. A percentage increase tells you how two risks compare. It leaves the size of either risk unresolved.
The useful reader question is: “Higher than what, for which outcome, over how long?” You can ask it before reading a variant code or interpreting a coloured badge. Keep the headline beside the study link so you can check whether the writer has preserved the researchers’ measure.
Put the denominator back
The National Cancer Institute defines absolute risk as the chance of an event over a stated period. Its definition concerns cancer; the same arithmetic distinction helps you read other risk claims. The starting population and timeframe belong beside the number.
Consider a made-up study of an unnamed outcome. Researchers observe that 20 of 1,000 people in one group experience it over ten years, compared with 30 of 1,000 in another. The risks are 2% and 3%. The second group has ten additional events per 1,000 people, an increase of one percentage point.
The relative increase is 50%, because ten extra events divided by the starting twenty equals one half. Both descriptions refer to the same example. Neither estimates your health risk. We invented these numbers to show the arithmetic, with no disease, genetic variant or treatment attached.
Now change the starting risk to 200 in 1,000 and the comparison to 300 in 1,000. You still get a 50% relative increase, but the absolute difference is 100 events per 1,000. A headline that keeps only the relative increase hides that distinction.
Preserve the researchers’ measure
NCI’s relative-risk definition describes a comparison between groups. Check whether the paper reports a risk ratio, an odds ratio or another measure. Copy the label alongside the number instead of replacing it with “chance”.
An odds ratio compares odds. In the first fictional group, the odds are 20 events against 980 non-events. In the second, they are 30 against 970. The ratio of those odds is about 1.52; the risk ratio is 1.5. They look close in this example, but they describe different quantities.
You do not need to convert a paper’s statistic into a personal probability. Save its original wording and ask the report provider to explain it. A decimal with several digits can still leave the prediction period or comparison population unspecified.
Check the outcome before the adjective
Write down what the researchers counted. A diagnosis, a laboratory measurement and a self-reported symptom answer different questions. A headline about a “gene for” a condition may skip those details. Ask for the endpoint in the methods or results section, using the researchers’ wording.
Separate a group comparison from a decision about your care. The FDA’s consumer-test guidance explains that genetic risk contributes only part of overall risk and that consumer results need clinical context. A positive genetic health-risk result does not establish that you will develop the condition.
For your reading notes, use one sentence: “In this study’s population, the researchers compared this outcome over this period using this measure.” Leave a blank where the article supplies no answer. That blank records an information gap; it does not justify filling the gap with an internet calculator.
One next step
Keep the original headline in your note as well as your rewrite. Another reader can then see which information you added from the paper and which information the headline omitted. Label any arithmetic you perform as your calculation.
Take one genetic-risk headline and rewrite it with its starting risk, comparison group and timeframe. If those details are missing, ask the source or report provider for them. Bring personal medical questions to the team responsible for your care.
You can explore DomDNA’s educational quiz for general lifestyle topics. It does not analyse DNA, calculate your disease risk or choose screening.
Original source and access ledger
- NCI absolute risk
sourceDate: Revision date not established; accessed 2026-10-04
type: Government cancer glossary
population: Cancer-risk communication
endpoint: Event probability over a stated period
supportedClaimAndLimit: Absolute risk requires a defined event, population and timeframe; no personal probability inferred.
fundingAndConflicts: Official educational or technical documentation; no product endorsement inferred.
accessEvidence: Relevant source text opened via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
- NCI relative risk
sourceDate: Revision date not established; accessed 2026-10-04
type: Government cancer glossary
population: Comparisons of groups in cancer research
endpoint: Ratio of event risks
supportedClaimAndLimit: Relative risk compares groups; it leaves the starting probability unspecified.
fundingAndConflicts: Official educational or technical documentation; no product endorsement inferred.
accessEvidence: Relevant source text opened via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
- NCI odds ratio
sourceDate: Revision date not established; accessed 2026-10-04
type: Government cancer glossary
population: Observational comparisons
endpoint: Ratio of event odds
supportedClaimAndLimit: Odds and probabilities differ; preserve the paper's statistical measure.
fundingAndConflicts: Official educational or technical documentation; no product endorsement inferred.
accessEvidence: Relevant source text opened via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
- FDA consumer-test limits
sourceDate: Revision date not established; accessed 2026-10-04
type: Government consumer guidance
population: US direct-to-consumer testing
endpoint: Interpretation limits
supportedClaimAndLimit: Genetic health-risk reports do not determine overall disease risk; US guidance, no product approval inferred.
fundingAndConflicts: Official educational or technical documentation; no product endorsement inferred.
accessEvidence: Relevant source text opened via web on 2026-10-04; no personal health data transmitted.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction or guideline-surveillance audit claimed.
Download exact original article Markdown · Download exact source and unsent social pack
Finished companion media
Silent films, slides and source captions on the separate dashboard. Original preview and historical product limits remain in their captions. No social campaign has been sent.